COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis

Prabani, K.I.P.; Weerasekara, Ishanka; Damayanthi, Hewaratne Dassanayakege Wimala Thushari

doi:10.1016/j.puhe.2022.09.001

Cited by 31 publications

(22 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with cancer have been described to be more hesitant to undergo COVID-19 vaccination, as demonstrated by a global population-based study exploring factors associated with vaccination intention against COVID-19, which showed that more patients with a history of cancer in the past 5 years were unwilling to receive vaccination against COVID-19 (61%) vs those without a history of cancer (14%) [22]. A meta-analysis on COVID-19 vaccine acceptance and hesitancy among patients with cancer, including 29 studies, found a pooled prevalence of vaccine acceptance of 59% and a pooled prevalence of vaccine hesitancy due to fear of vaccine-related side-effects of 53% [11]. However, adequate vaccination rates against COVID-19 in our study reached 67%, similar to the reported prevalence of adequate vaccination against COVID-19 among patients with cancer in a large cross-sectional study in Bosnia and Herzegovina (64%) [23].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Vaccination status and attitudes towards COVID-19 vaccination in patients undergoing active cancer treatment in a referral center in Mexico: a survey study

Martínez-Cannon

Garcia-Ronquillo

2023

Support Care Cancer

View full text Add to dashboard Cite

Background COVID-19 vaccination refusal/hesitancy among patients with cancer has been reported to be high. This study aimed to assess vaccination status and attitudes towards COVID-19 vaccines in patients with cancer undergoing active treatment in a single center in Mexico. Methods A cross-sectional, 26-item survey evaluating vaccination status and attitudes towards COVID-19 vaccination was conducted among patients undergoing active cancer treatment. Descriptive statistics were used to analyze the sociodemographic characteristics, vaccination status, and attitudes. X2 tests and multivariate analysis were used to evaluate associations between characteristics and attitudes with adequate vaccination status. Results Of 201 respondents, 95% had received at least one dose, and 67% had adequate COVID-19 vaccination status (≥ 3 doses). Thirty-six percent of patients had at least one reason for doubting/rejecting vaccination, and the main reason was being afraid of side effects. On multivariate analysis, age ≥ 60 years (odds ratio (OR) 3.77), mass media as main source of information on COVID-19 (OR 2.55), agreeing vaccination against COVID-19 is safe in patients with cancer (OR 3.11), and not being afraid of the composition of the COVID-19 vaccines (OR 5.10) statistically increased the likelihood of adequate vaccination status. Conclusions Our study shows high vaccination rates and positive attitudes towards COVID-19 vaccines, with a significant proportion of patients undergoing active cancer treatment with adequate vaccination status (≥ 3 doses). Older age, use of mass media as main source of COVID-19 information, and positive attitudes towards COVID-19 vaccines were significantly associated with a higher likelihood of adequate COVID-19 vaccination status among patients with cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Similarly, the Mexican Society of Oncology (SMEO) also recommends vaccination against COVID-19 in all adult patients with cancer [10]. Nonetheless, COVID-19 vaccination refusal or hesitancy among patients with cancer has been reported to be high [11].…”

Section: Introductionmentioning

confidence: 99%

Vaccination status and attitudes towards COVID-19 vaccination in patients undergoing active cancer treatment in a referral center in Mexico: a survey study

Martínez-Cannon

Garcia-Ronquillo

2023

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…Vaccine hesitancy is a well-known phenomenon, and World Health Organization recognizes it as one of the top ten threats to global health in 2019 [ 48 ]. Especially during the pandemic, lack of accurate knowledge about vaccines, confusing messages about vaccine safety and side effects, anti-vaccine myths, conspiracy beliefs, mistrust and suspicion of medical companies, and reduced trust in government and healthcare professionals increase vaccine hesitancy to COVID-19 and influenza vaccines [ 49 , 50 , 51 , 52 ].…”

Section: Discussionmentioning

confidence: 99%

Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic

et al. 2023

View full text Add to dashboard Cite

High-risk populations are at increased risk of severe influenza-related illness, hospitalization, and death due to influenza. The aim of our study was to assess the willingness of high-risk populations to take the influenza vaccine for the 2022–2023 season, and to investigate the factors associated with such willingness. We conducted a cross-sectional study in Greece in September 2022 using a convenience sample. We considered demographic characteristics, COVID-19-related variables, resilience, social support, anxiety, depression, and COVID-19-related burnout as potential predictors. Among participants, 39.4% were willing to accept the seasonal influenza vaccine, 33.9% were unwilling, and 26.8% were hesitant. Multivariable analysis identified that increased age and increased family support were associated with increased influenza vaccination willingness. Moreover, participants that have received COVID-19 booster doses were more willing to accept the influenza vaccine. In contrast, adverse effects because of COVID-19 vaccination and exhaustion due to measures against COVID-19 reduced influenza vaccination willingness. We found that the intention of high-risk populations to receive the influenza vaccine was low. Our study contributes to an increased understanding of the factors that affect vaccination willingness. Public health authorities could use this information to update vaccination programs against influenza. Emphasis should be given on safety and effectiveness issues.

show abstract

“…In addition, our results support the importance of SARS-Cov-2 vaccination in cancer patients. Indeed, vaccine hesitancy was present in all populations, including patients with cancer ( 51 , 52 , 53 ), as demonstrated by a large meta-analysis that found only 59% vaccine acceptance ( 53 ).…”

Section: Discussionmentioning

confidence: 99%

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

et al. 2023

View full text Add to dashboard Cite

COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis

Cited by 31 publications

References 44 publications

Vaccination status and attitudes towards COVID-19 vaccination in patients undergoing active cancer treatment in a referral center in Mexico: a survey study

Vaccination status and attitudes towards COVID-19 vaccination in patients undergoing active cancer treatment in a referral center in Mexico: a survey study

Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

Contact Info

Product

Resources

About